Skip to main content
. 2012 Jun 26;3(6):503–509. doi: 10.1111/j.2040-1124.2012.00221.x

Table 1. Time course of glycated hemoglobin levels in patients in the monotherapy and combination therapy groups.

  HbA1c (%) ΔHbA1c (0–12 weeks)
  Baseline 4 weeks 12 weeks  
Total (n = 741) 8.04 ± 1.14 7.69 ± 1.01* 7.28 ± 0.86*,** 0.76 ± 0.87
Monotherapy (n = 110) 7.88 ± 1.54 7.59 ± 1.20* 7.09 ± 0.71*,** 0.79 ± 1.33
Combination therapy (n = 631) 8.07 ± 1.06 7.71 ± 0.97* 7.31 ± 0.88*,** 0.76 ± 0.77

anova: vs baseline *P < 0.01, vs 4 weeks **P < 0.01. HbA1c, glycated hemoglobin.